James Berger, Chief Commercial Officer in Hofseth BioCare ASA, has today 01.10.2021 purchased 30,000 shares through his wholly-owned company Nevera AG, at an average price of NOK 6,65 per share.
Following this transaction, James Berger owns 3,297,955 shares corresponding to 0.92 % of the outstanding shares in Hofseth BioCare ASA and share options for a further 5,351,280 shares according to the stock exchange notice of 18.10.2019.
For further information, please contact:
Jon Olav Ødegård, CFO of Hofseth BioCare ASA
Phone: +47 936 32 966
E-mail: joo@hofsethbiocare.no
This information is subject to the disclosure requirements pursuant to Section 5-12 of the Norwegian Securities Trading Act
